Literature DB >> 15206993

Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.

Jari J Lilja1, Mikko Neuvonen, Pertti J Neuvonen.   

Abstract

AIMS: Simvastatin, a substrate for CYP3A4, is extensively metabolized during the first pass. Our aim was to investigate the effect of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.
METHODS: In a randomized cross-over study with two phases, 10 healthy volunteers ingested grapefruit juice 200 ml or water (control) for 3 days. On day 3, a single 40-mg dose of simvastatin was administered with grapefruit juice 200 ml or water. Plasma concentrations of simvastatin and simvastatin acid were determined up to 24 h.
RESULTS: Grapefruit juice increased the area under the plasma concentration-time curves from 0 to 24 h [AUC(0-24)] of simvastatin 3.6-fold (range 1.8-6.0-fold; P < 0.01) and that of simvastatin acid 3.3-fold (range 2.1-5.6-fold; P < 0.01), respectively. The peak concentrations (C(max)) of simvastatin and simvastatin acid were increased 3.9-fold (range 2.3-9.3-fold; P < 0.01) and 4.3-fold (range 2.7-7.9-fold; P < 0.01) by grapefruit juice.
CONCLUSIONS: Even one glass of grapefruit juice, taken daily, considerably increases the plasma concentrations of simvastatin and simvastatin acid. Grapefruit juice may increase both the cholesterol-lowering effect and the risk of adverse effects of simvastatin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206993      PMCID: PMC1884539          DOI: 10.1111/j.1365-2125.2004.02095.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Interaction of citrus juices with felodipine and nifedipine.

Authors:  D G Bailey; J D Spence; C Munoz; J M Arnold
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

2.  The interaction of diltiazem with simvastatin.

Authors:  O Mousa; D C Brater; K J Sunblad; S D Hall
Journal:  Clin Pharmacol Ther       Date:  2000-03       Impact factor: 6.875

3.  Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.

Authors:  J D Rogers; J Zhao; L Liu; R D Amin; K D Gagliano; A G Porras; R A Blum; M F Wilson; M Stepanavage; J M Vega
Journal:  Clin Pharmacol Ther       Date:  1999-10       Impact factor: 6.875

4.  Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis.

Authors:  N Kanathur; M G Mathai; R P Byrd; C L Fields; T M Roy
Journal:  Tenn Med       Date:  2001-09

5.  Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin.

Authors:  J J Lilja; K T Kivistö; P J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2000-10       Impact factor: 6.875

6.  Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.

Authors:  J J Lilja; K T Kivistö; P J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  1999-08       Impact factor: 6.875

7.  Disposition of intravenous and oral cyclosporine after administration with grapefruit juice.

Authors:  M P Ducharme; L H Warbasse; D J Edwards
Journal:  Clin Pharmacol Ther       Date:  1995-05       Impact factor: 6.875

8.  Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.

Authors:  S Vickers; C A Duncan; I W Chen; A Rosegay; D E Duggan
Journal:  Drug Metab Dispos       Date:  1990 Mar-Apr       Impact factor: 3.922

9.  In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.

Authors:  S Vickers; C A Duncan; K P Vyas; P H Kari; B Arison; S R Prakash; H G Ramjit; S M Pitzenberger; G Stokker; D E Duggan
Journal:  Drug Metab Dispos       Date:  1990 Jul-Aug       Impact factor: 3.922

10.  Interaction between grapefruit juice and midazolam in humans.

Authors:  H H Kupferschmidt; H R Ha; W H Ziegler; P J Meier; S Krähenbühl
Journal:  Clin Pharmacol Ther       Date:  1995-07       Impact factor: 6.875

View more
  34 in total

Review 1.  Potential of pharmacokinetic profiling for detecting herbal interactions with drugs.

Authors:  Veronika Butterweck; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

2.  Effects of grapefruit juice on the pharmacokinetics of acebutolol.

Authors:  Jari J Lilja; Kari Raaska; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 4.  Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors:  David G Bailey; George Dresser; J Malcolm O Arnold
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

5.  Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.

Authors:  Garrett R Ainslie; Kristina K Wolf; Yingxin Li; Elizabeth A Connolly; Yolanda V Scarlett; J Heyward Hull; Mary F Paine
Journal:  J Pharmacol Exp Ther       Date:  2014-09-24       Impact factor: 4.030

6.  An LC-MS assay for the screening of cardiovascular medications in human samples.

Authors:  Eduardo Dias; Brian Hachey; Candace McNaughton; Hui Nian; Chang Yu; Brittany Straka; Nancy J Brown; Richard M Caprioli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-08-16       Impact factor: 3.205

Review 7.  Intensive management of risk factors for accelerated atherosclerosis: the role of multiple interventions.

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 8.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 9.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 10.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.